|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Harmony Biosciences Holdings, Inc. (HRMY) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
63,680,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$ - $ |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Harmony Biosciences is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological disorders. Co.'s product, WAKIX (pitolisant), is a first-in-class molecule with a novel mechanism of action, specifically designed to increase histamine signaling in the brain by binding to H3 receptors. WAKIX is used for the treatment of excessive daytime sleepiness (EDS), in adult patients with narcolepsy, focusing on the treatment of EDS associated with Prader-Willi Syndrome and myotonic dystrophy. Co. is also exploring pitolisant for treatments in other rare neurological disorders affected by fatigue and cognitive impairments.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
12,173 |
12,173 |
12,173 |
2,968,359 |
| Total Sell Value |
$389,536 |
$389,536 |
$389,536 |
$166,425,443 |
| Total People Sold |
1 |
1 |
1 |
6 |
| Total Sell Transactions |
2 |
2 |
2 |
56 |
| End Date |
2024-02-08 |
2023-11-07 |
2023-05-09 |
2022-05-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Dayno Jeffrey M. |
Chief Medical Officer |
• – – |
2021-07-22 |
4 |
AS |
$30.00 |
$1,500 |
D/D |
(50) |
0 |
|
- |
|
| Dayno Jeffrey M. |
Chief Medical Officer |
• – – |
2021-07-22 |
4 |
OE |
$8.22 |
$411 |
D/D |
50 |
50 |
|
- |
|
| Nielsen Jack |
Director |
– • – |
2020-08-26 |
4 |
B |
$34.30 |
$134,525 |
I/I |
3,922 |
42,702 |
2.1 |
- |
|
| Nielsen Jack |
Director |
– • – |
2020-08-25 |
4 |
B |
$34.20 |
$28,147 |
I/I |
823 |
38,780 |
2.1 |
- |
|
| Nielsen Jack |
Director |
– • – |
2020-08-24 |
4 |
B |
$34.30 |
$104,855 |
I/I |
3,057 |
37,957 |
2.1 |
- |
|
| Marshman Fund Trust Ii |
10% Owner |
– – • |
2020-08-21 |
4 |
B |
$24.00 |
$8,147,424 |
D/D |
339,476 |
10,651,120 |
2.45 |
- |
|
| Novo A/s |
10% Owner |
– – • |
2020-08-21 |
4/A |
A |
$0.00 |
$0 |
D/D |
3,622,470 |
3,754,973 |
|
- |
|
| Serafin Andrew |
Chief Business Officer |
• – – |
2020-08-21 |
4/A |
A |
$0.00 |
$0 |
D/D |
33,693 |
33,693 |
|
- |
|
| Marshman Fund Trust Ii |
10% Owner |
– – • |
2020-08-21 |
4/A |
A |
$0.00 |
$0 |
D/D |
3,379,881 |
3,379,881 |
|
- |
|
| Sabater Juan A. |
Director |
– • • |
2020-08-21 |
4/A |
A |
$0.00 |
$0 |
D/D |
10,372,697 |
11,218,033 |
|
- |
|
| Novo A/s |
10% Owner |
– – • |
2020-08-21 |
4 |
B |
$24.00 |
$3,180,072 |
D/D |
132,503 |
4,409,803 |
2.45 |
- |
|
| Novo A/s |
10% Owner |
– – • |
2020-08-21 |
4 |
A |
$0.00 |
$0 |
D/D |
4,277,300 |
4,277,300 |
|
- |
|
| Sabater Juan A. |
Director |
– • • |
2020-08-21 |
4 |
A |
$0.00 |
$0 |
D/D |
12,321,020 |
13,166,357 |
|
- |
|
| Serafin Andrew |
Chief Business Officer |
• – – |
2020-08-21 |
4 |
A |
$0.00 |
$0 |
D/D |
39,085 |
39,085 |
|
- |
|
| Marshman Fund Trust Ii |
10% Owner |
– – • |
2020-08-21 |
4 |
A |
$0.00 |
$0 |
D/D |
4,026,784 |
10,958,547 |
|
- |
|
| Nielsen Jack |
Director |
– • – |
2020-08-21 |
4 |
B |
$24.00 |
$846,191 |
I/I |
32,164 |
34,900 |
2.1 |
- |
|
| Nielsen Jack |
Director |
– • – |
2020-08-20 |
4 |
B |
$35.00 |
$95,760 |
I/I |
2,736 |
2,736 |
2.1 |
- |
|
| Marshman Fund Trust Ii |
10% Owner |
– – • |
2020-08-18 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
6,931,763 |
|
- |
|
| Sabater Juan A. |
Director |
– • • |
2020-08-18 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
845,336 |
|
- |
|
169 Records found
|
|
Page 7 of 7 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
